The weekly litigation news digest is live. Subscribe now

IP Verse

Anthrogenesis competitive analysis

Loading summary...

Latest patents of Anthrogenesis opposed by its competitors

Explore Anthrogenesis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3204022
Dec 2, 2020Placenta-Derived Adherent Cell Exosomes And Uses Thereof1
EP3088512
Dec 11, 2019Use Of Placental Stem Cells For Treating Heart And Circulatory Diseases By Promoting Angiogenesis1

Latest PTAB cases involving Anthrogenesis

Discover the latest PTAB cases involving Anthrogenesis, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Anthrogenesis with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ANTHROGENESIS - 2 - -
D YOUNG29 - - -